Abera Bioscience AB (XSAT:ABERA) Total Liabilities : kr2.45 Mil (As of Mar. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Abera Bioscience AB Total Liabilities?

Abera Bioscience AB's Total Liabilities for the quarter that ended in Mar. 2024 was kr2.45 Mil.

Abera Bioscience AB's quarterly Total Liabilities increased from Sep. 2023 (kr2.26 Mil) to Dec. 2023 (kr3.69 Mil) but then declined from Dec. 2023 (kr3.69 Mil) to Mar. 2024 (kr2.45 Mil).

Abera Bioscience AB's annual Total Liabilities increased from Dec. 2021 (kr2.22 Mil) to Dec. 2022 (kr2.80 Mil) and increased from Dec. 2022 (kr2.80 Mil) to Dec. 2023 (kr3.69 Mil).

Abera Bioscience AB Total Liabilities Historical Data

The historical data trend for Abera Bioscience AB's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Abera Bioscience AB Total Liabilities Chart

Abera Bioscience AB Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Liabilities

Get a 7-Day Free Trial

0.82

2.54

2.22

2.80

3.69

Abera Bioscience AB Quarterly Data
	Dec18	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Liabilities	Get a 7-Day Free Trial														4.08	3.02	2.26	3.69	2.45

Abera Bioscience AB Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Abera Bioscience AB's Total Liabilities for the fiscal year that ended in Dec. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	3.692	+	(0	+	0
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	3.69

Total Liabilities	=	Total Assets (A: Dec. 2023 )	-	Total Equity (A: Dec. 2023 )
	=	9.35	-	5.658
	=	3.69

Abera Bioscience AB's Total Liabilities for the quarter that ended in Mar. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	2.452	+	(0	+	0
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	2.45

Total Liabilities	=	Total Assets (Q: Mar. 2024 )	-	Total Equity (Q: Mar. 2024 )
	=	11.719	-	9.267
	=	2.45

Abera Bioscience AB Total Liabilities Related Terms

Thank you for viewing the detailed overview of Abera Bioscience AB's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Abera Bioscience AB (XSAT:ABERA) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Abera Bioscience AB (XSAT:ABERA) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

N/A

Address

Svetsarvagen 15, Solna, SWE, SE-17141

Website

https://www.aberabio.com

Abera Bioscience AB is a platform and vaccine development company based on research in the medical, molecular, and microbiological fields. The company's mission is to develop vaccine candidates based on its novel vaccine delivery platform to late pre-clinical or early clinical phase.

Abera Bioscience AB (XSAT:ABERA) Headlines

No Headlines